Cartesian Therapeutics (RNAC) Shares Issued: 2015-2025
Historic Shares Issued for Cartesian Therapeutics (RNAC) over the last 8 years, with Sep 2025 value amounting to $5,000.
- Cartesian Therapeutics' Shares Issued fell 100.00% to $5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $121.8 million, marking a year-over-year decrease of 2.27%. This contributed to the annual value of $124.4 million for FY2024, which is 53769.26% up from last year.
- Cartesian Therapeutics' Shares Issued amounted to $5,000 in Q3 2025, which was down 94.12% from $85,000 recorded in Q2 2025.
- Cartesian Therapeutics' Shares Issued's 5-year high stood at $121.6 million during Q3 2024, with a 5-year trough of -$20.3 million in Q2 2021.
- For the 3-year period, Cartesian Therapeutics' Shares Issued averaged around $17.8 million, with its median value being $149,000 (2023).
- Its Shares Issued has fluctuated over the past 5 years, first tumbled by 2,140.06% in 2021, then spiked by 148,145.12% in 2024.
- Cartesian Therapeutics' Shares Issued (Quarterly) stood at $104,000 in 2021, then plummeted by 1,650.00% to -$31,000 in 2022, then skyrocketed by 364.52% to $82,000 in 2023, then spiked by 148,145.12% to $121.6 million in 2024, then tumbled by 100.00% to $5,000 in 2025.
- Its last three reported values are $5,000 in Q3 2025, $85,000 for Q2 2025, and $183,000 during Q1 2025.